Back to Search
Start Over
On the Alert for Cytokine Storm: Immunopathology in COVID-19.
- Source :
-
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2020 Jul; Vol. 72 (7), pp. 1059-1063. Date of Electronic Publication: 2020 May 10. - Publication Year :
- 2020
-
Abstract
- Poor outcomes in COVID-19 correlate with clinical and laboratory features of cytokine storm syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy may prevent immunopathology and could help conserve limited health care resources. While studies are ongoing, extrapolating from clinical experience in cytokine storm syndromes may benefit the multidisciplinary teams caring for patients with severe COVID-19.<br /> (© 2020, American College of Rheumatology.)
- Subjects :
- Betacoronavirus
Biomarkers
COVID-19
Coronavirus Infections complications
Coronavirus Infections therapy
Cytokine Release Syndrome diagnosis
Early Medical Intervention
Humans
Pandemics
Pneumonia, Viral complications
Pneumonia, Viral therapy
SARS-CoV-2
Anti-Inflammatory Agents therapeutic use
Coronavirus Infections immunology
Cytokine Release Syndrome drug therapy
Cytokine Release Syndrome virology
Pneumonia, Viral immunology
Subjects
Details
- Language :
- English
- ISSN :
- 2326-5205
- Volume :
- 72
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Arthritis & rheumatology (Hoboken, N.J.)
- Publication Type :
- Academic Journal
- Accession number :
- 32293098
- Full Text :
- https://doi.org/10.1002/art.41285